Comparing Long‐Term Infliximab Persistence Following a Switch to a Biosimilar in Patients With Inflammatory Bowel Disease: No Cause for Concern

Paulina Suo, Craig Haifer, Daniel R. van Langenberg et al.|Journal of Gastroenterology and Hepatology|2025

Cited by 0